AzPA Pharmacy Flash

• Quantifying pharmacists' clinical interventions with specialty pharmacy in a pediatric ambulatory setting
  In a retrospective, single-center, cohort study, results demonstrated that pharmacists at a pediatric health system specialty pharmacy performed clinical interventions beyond daily activities, which resulted in a significant financial impact.
• FDA approves pirtobrutinib for treatment of adult patients with CLL, SLL
  The FDA has approved 50 mg and 100 mg tablets of pirtobrutinib for the treatment of adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least 2 prior lines of therapy, including a Bruton's tyrosine kinase inhibitor and a BCL-2 inhibitor.
• Pharmacy Forecast Report: Societal issues poised to transform healthcare delivery
  The rise of innovative and ultra-high-cost new treatments, which often come with complex delivery systems, provide new hope for preventing, curing and treating devastating diseases.